Skip to Main Content

Author Details

David Jeffrey Demanes
University of California los angeles
1978
86
27
PMIDPaper TitleJournal TitlePublished Year
36179990External Beam Radiation Therapy With or Without Brachytherapy Boost in Men With Very-High-Risk Prostate Cancer: A Large Multicenter International Consortium Analysis.Int J Radiat Oncol Biol Phys2023
35050303Interplay Between Duration of Androgen Deprivation Therapy and External Beam Radiotherapy With or Without a Brachytherapy Boost for Optimal Treatment of High-risk Prostate Cancer: A Patient-Level Data Analysis of 3 Cohorts.JAMA Oncol2022
34196715Comparison of Multimodal Therapies and Outcomes Among Patients With High-Risk Prostate Cancer With Adverse Clinicopathologic Features.JAMA Netw Open2021
33487561Brachytherapy of the head and neck: An University of California Los Angeles guide to morbidity reduction.Brachytherapy2021
34902034Performance of a Prostate-Specific Membrane Antigen Positron Emission Tomography/Computed Tomography-Derived Risk-Stratification Tool for High-risk and Very High-risk Prostate Cancer.JAMA Netw Open2021
33985797Patterns of Clinical Progression in Radiorecurrent High-risk Prostate Cancer.Eur Urol2021
30992160Prostate-only Versus Whole-pelvis Radiation with or Without a Brachytherapy Boost for Gleason Grade Group 5 Prostate Cancer: A Retrospective Analysis.Eur Urol2020
31688338Glaucoma After Iodine-125 Brachytherapy for Uveal Melanoma: Incidence and Risk Factors.J Glaucoma2020
27281263Targeted Prostate Biopsy Gleason Score Heterogeneity and Implications for Risk Stratification.Am J Clin Oncol2018
30212298The American Brachytherapy Society and the American Radium Society Appropriate Use Criteria Genitourinary Committee Endorse the American Society of Clinical Oncology/Cancer Care Ontario Guidelines.J Clin Oncol2018
29976500Clinical Outcomes for Patients With Gleason Score 10 Prostate Adenocarcinoma: Results From a Multi-institutional Consortium Study.Int J Radiat Oncol Biol Phys2018
29573121Head and neck cancer reirradiation with interstitial high-dose-rate brachytherapy.Head Neck2018
29509865Radical Prostatectomy, External Beam Radiotherapy, or External Beam Radiotherapy With Brachytherapy Boost and Disease Progression and Mortality in Patients With Gleason Score 9-10 Prostate Cancer.JAMA2018
29128230Clinical outcomes using image-guided interstitial brachytherapy for definitive cervical cancer patients with high-risk clinical target volumes greater than 30 cc.Brachytherapy2018
28856847Comparison of patient-reported acute urinary and sexual toxicity scores in a 6- versus 2-fraction course of high-dose-rate prostate brachytherapy monotherapy.J Med Imaging Radiat Oncol2018
28537990Impact of the Primary Information Source Used for Decision Making on Treatment Perceptions and Regret in Prostate Cancer.Am J Clin Oncol2018
27672743Outcomes of Node-positive Breast Cancer Patients Treated With Accelerated Partial Breast Irradiation Via Multicatheter Interstitial Brachytherapy: The Pooled Registry of Multicatheter Interstitial Sites (PROMIS) Experience.Am J Clin Oncol2018
27322703A Pooled Analysis of Biochemical Failure in Intermediate-risk Prostate Cancer Following Definitive Stereotactic Body Radiotherapy (SBRT) or High-Dose-Rate Brachytherapy (HDR-B) Monotherapy.Am J Clin Oncol2018
27288156American Brachytherapy Society Task Group Report: Long-term control and toxicity with brachytherapy for localized breast cancer.Brachytherapy2017
28109634The American College of Radiology and the American Brachytherapy Society practice parameter for the performance of radionuclide-based high-dose-rate brachytherapy.Brachytherapy2017
28126301Exploring Value From the Patient's Perspective Between Modern Radiation Therapy Modalities for Localized Prostate Cancer.Int J Radiat Oncol Biol Phys2017
28988661American College of Radiology-American Brachytherapy Society practice parameter for electronically generated low-energy radiation sources.Brachytherapy2017
28597076Juxtapapillary and circumpapillary choroidal melanoma: globe-sparing treatment outcomes with iodine-125 notched plaque brachytherapy.Graefes Arch Clin Exp Ophthalmol2017
28807747Pretreatment 3T multiparametric MRI staging predicts for biochemical failure in high-risk prostate cancer treated with combination high-dose-rate brachytherapy and external beam radiotherapy.Brachytherapy2017
27965117High-dose-rate brachytherapy monotherapy without androgen deprivation therapy for intermediate-risk prostate cancer.Brachytherapy2017
27452951Clinical Outcomes for Patients with Gleason Score 9-10 Prostate Adenocarcinoma Treated With Radiotherapy or Radical Prostatectomy: A Multi-institutional Comparative Analysis.Eur Urol2017
26850649SBRT and HDR brachytherapy produce lower PSA nadirs and different PSA decay patterns than conventionally fractionated IMRT in patients with low- or intermediate-risk prostate cancer.Pract Radiat Oncol2016
26443877High-Dose-Rate Monotherapy for Localized Prostate Cancer: 10-Year Results.Int J Radiat Oncol Biol Phys2016
2763870223-mm iodine-125 plaque for uveal melanoma: benefit of vitrectomy and silicone oil on visual acuity.Graefes Arch Clin Exp Ophthalmol2016
28029448Long term results from a prospective database on high dose rate (HDR) interstitial brachytherapy for primary cervical carcinoma.Gynecol Oncol2016
27743957Locoregional recurrence by molecular subtype after multicatheter interstitial accelerated partial breast irradiation: Results from the Pooled Registry Of Multicatheter Interstitial Sites research group.Brachytherapy2016
27370161Comment on "Medical use of all high activity sources should be eliminated for security concerns" [Med. Phys. 42, 6773-6775 (2015)].Med Phys2016
26884564Brachytherapy: Where Has It Gone⿦Again?J Clin Oncol2016
25537448A sector-based dosimetric analysis of dose heterogeneity in high-dose-rate prostate brachytherapy.Brachytherapy2015
26622237Image-guided high-dose-rate brachytherapy: preliminary outcomes and toxicity of a joint interventional radiology and radiation oncology technique for achieving local control in challenging cases.J Contemp Brachytherapy2015
26022354Quantitative multiparametric MRI in uveal melanoma: increased tumor permeability may predict monosomy 3.Neuroradiology2015
25944395Dosimetric comparison of brachyablation and stereotactic ablative body radiotherapy in the treatment of liver metastasis.Brachytherapy2015
26024784Early clinical outcomes of ultrasound-guided CT-planned high-dose-rate interstitial brachytherapy for primary locally advanced cervical cancer.Brachytherapy2015
25680768From whole gland to hemigland to ultra-focal high-dose-rate prostate brachytherapy: A dosimetric analysis.Brachytherapy2015
25556864Ureteral stent insertion for gynecologic interstitial high-dose-rate brachytherapy.Brachytherapy2015
24709516Multiparametric MRI identifies and stratifies prostate cancer lesions: implications for targeting intraprostatic targets.Brachytherapy2014
25085454High-dose-rate brachytherapy as monotherapy for prostate cancer.Brachytherapy2014
24927922A critical ACR appropriateness Criteria omission.Brachytherapy2014
22652111High-dose-rate prostate brachytherapy consistently results in high quality dosimetry.Int J Radiat Oncol Biol Phys2013
24138921Dosimetric comparison of 3-dimensional planning techniques using an intravaginal multichannel balloon applicator for high-dose-rate gynecologic brachytherapy.Int J Radiat Oncol Biol Phys2013
24222860Quantifying the ki-67 heterogeneity profile in prostate cancer.Prostate Cancer2013
24143146Predictors of distant metastasis after combined HDR brachytherapy and external beam radiation for prostate cancer.J Contemp Brachytherapy2013
23434220American Brachytherapy Society (ABS) consensus statement for sarcoma brachytherapy.Brachytherapy2013
23406987Focal high-dose-rate brachytherapy: a dosimetric comparison of hemigland vs. conventional whole-gland treatment.Brachytherapy2013
23453681American Brachytherapy Society-Groupe Européen de Curiethérapie-European Society of Therapeutic Radiation Oncology (ABS-GEC-ESTRO) consensus statement for penile brachytherapy.Brachytherapy2013
  • 1 - 50 of 86

Recommended Authors

Maureen Bojador
University of Santo Tomas Hospital
Career Start Year 2017
Number of shared co-authors 1
Hilary P Bagshaw
Stanford University
Career Start Year 2014
Number of shared co-authors 30
Niluja Thiruthaneeswaran
The University of Sydney, Westmead Hospital
Career Start Year 2014
Number of shared co-authors 3
Rachel M Glicksman
University of Toronto, Princess Margaret Cancer Centre, University Health Network
Career Start Year 2013
Number of shared co-authors 19
Xin Pei
Memorial Sloan Kettering Cancer Center
Career Start Year 2010
Number of shared co-authors 4
Alan Dal Pra
University of Miami Miller School of Medicine
Career Start Year 2010
Number of shared co-authors 14
Suneil Jain
Cancer Centre Belfast City Hospital, Queen's University Belfast
Career Start Year 2008
Number of shared co-authors 6
Jure Murgic
University Hospital Center Sestre Milosrdnice
Career Start Year 2008
Number of shared co-authors 3
Bridget F Koontz
Duke University School of Medicine
Career Start Year 2006
Number of shared co-authors 23
Himanshu Nagar
New York-Presbyterian Hospital, Weill Cornell Medical Center
Career Start Year 2005
Number of shared co-authors 15
Ananya Choudhury
University of Manchester and The Christie NHS Foundation Trust
Career Start Year 2004
Number of shared co-authors 11
Neil B Desai
University of Texas Southwestern Medical Center
Career Start Year 2004
Number of shared co-authors 24
Zhigang Zhang
Memorial Sloan Kettering Cancer Center
Career Start Year 2001
Number of shared co-authors 3
Amit Bahl
University Hospitals Bristol and Weston NHS Foundation Trust
Career Start Year 2001
Number of shared co-authors 2
Andrew K Lee
Texas Center for Proton Therapy
Career Start Year 2001
Number of shared co-authors 3
Robert B Den
Thomas Jefferson University Hospital
Career Start Year 1999
Number of shared co-authors 32
Constantine A Mantz
University of Chicago
Career Start Year 1997
Number of shared co-authors 29
Gert De Meerleer
University Hospitals Leuven
Career Start Year 1997
Number of shared co-authors 17
Vincent Khoo
The Royal Marsden NHS Foundation Trust and Institute of Cancer Research
Career Start Year 1996
Number of shared co-authors 7
Alan W Katz
University of Rochester
Career Start Year 1996
Number of shared co-authors 23
Simeng Suy
MedStar Georgetown University Hospital
Career Start Year 1996
Number of shared co-authors 27
Andrew Loblaw
Princess Margaret Hospital, University of Toronto
Career Start Year 1995
Number of shared co-authors 23
Glenn Bauman
Western University and London Regional Cancer Program
Career Start Year 1994
Number of shared co-authors 6
William L Barrett
Department of Radiation Oncology University of Cincinnati Cincinnati Ohio USA.
Career Start Year 1992
Number of shared co-authors 2
Jeff M Michalski
Washington University School of Medicine
Career Start Year 1990
Number of shared co-authors 52
Michael Milosevic
Princess Margaret Cancer Centre, University Health Network
Career Start Year 1990
Number of shared co-authors 4
Ivy A Petersen
Mayo Clinic
Career Start Year 1989
Number of shared co-authors 7
Peter Hoskin
Mount Vernon Cancer Centre
Career Start Year 1985
Number of shared co-authors 19
Andrzej Niemierko
Massachusetts General Hospital
Career Start Year 1982
Number of shared co-authors 11
Howard M Sandler
Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center
Career Start Year 1976
Number of shared co-authors 55

Collaborators

Mitchell Kamrava
Cedars Sinai Medical Center
Co-authored papers 38
Michael L Steinberg
University of California los angeles
Co-authored papers 26
Amar U Kishan
University of California los angeles
Co-authored papers 15
Patrick A Kupelian
university of california los angeles Medical Center
Co-authored papers 15
Eric M Horwitz
Fox Chase Cancer Center
Co-authored papers 11
Nicholas G Nickols
University of California, Veteran Affairs Greater Los Angeles Healthcare System
Co-authored papers 11
Robert E Reiter
David Geffen School of Medicine at university of california los angeles
Co-authored papers 9
Daniel J Krauss
William Beaumont School of Medicine
Co-authored papers 9
Christopher R King
University of California los angeles
Co-authored papers 9
Richard G Stock
Icahn School of Medicine at Mount Sinai
Co-authored papers 9
Darlene Veruttipong
Stanford University
Co-authored papers 8
Ryan Fiano
Urologic Research Institute, Ohio University School of Medicine
Co-authored papers 8
Phuoc T Tran
University of Maryland School of Medicine
Co-authored papers 8
Gregory S Merrick
Urologic Research Institute, Ohio University School of Medicine
Co-authored papers 8
Stephen Greco
Johns Hopkins University School of Medicine
Co-authored papers 8
Theodore L DeWeese
Johns Hopkins University School of Medicine
Co-authored papers 8
Danny Y Song
Johns Hopkins University School of Medicine
Co-authored papers 8
Eyad Abu-Isa
Ascension Providence Hospital
Co-authored papers 8
Wolfgang Lilleby
Oslo University Hospital
Co-authored papers 8
Curtiland Deville
Johns Hopkins University
Co-authored papers 8
Trude B Wedde
Oslo University Hospital
Co-authored papers 8
Daniel E Spratt
University Hospitals Seidman Cancer Center, Case Western Reserve University
Co-authored papers 8
Chandana A Reddy
Cleveland Clinic
Co-authored papers 8
Jay P Ciezki
Cleveland Clinic
Co-authored papers 8
Brian J Davis
Mayo Clinic
Co-authored papers 7
Ashley E Ross
Northwestern University
Co-authored papers 7
Jeffrey J Tosoian
Vanderbilt University Medical Center
Co-authored papers 7
Todd McNutt
Johns Hopkins University School of Medicine
Co-authored papers 7
Jonathan D Tward
Huntsman Cancer Institute, University of Utah
Co-authored papers 6
Eric A Klein
Cleveland Clinic
Co-authored papers 6
Release 1.2